Penumbra currently holds the majority market share for peripheral embolisation coils. Credit: TEEREXZ via Shutterstock. · Medical Device Network · TEEREXZ via Shutterstock. Penumbra has announced US ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

ALAMEDA, Calif., June 5, 2025 /PRNewswire/ -- Penumbra, Inc (PEN). (NYSE: PEN) announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby ® XL System, the longest, largest ...

ALAMEDA, Calif., June 5, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby® XL System, the longest, largest and ...

"We've engineered Ruby XL to deliver more volume per coil than any other coil on the market, which may result in cost savings," said Shruthi Narayan, President of Interventional Business at Penumbra, ...